Jpmorgan Chase & CO Clear Point Neuro, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 24,209 shares of CLPT stock, worth $285,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,209
Previous 548
4317.7%
Holding current value
$285,908
Previous $8,000
3487.5%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
8.14MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.28MShares$15.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$8.75 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$5.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.33 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$3.91 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $289M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...